The nominating committee and the board of directors ("Board") of Biolidics Limited have reviewed, assessed and concluded that Mr. Liew Yoke Pheng Joseph ("Mr Liew") possesses the requisite experience, qualifications, skill sets and competencies, and is considered independent, to be appointed as an independent director of the Company and concurrently as the chairman of the audit committee and a member of nominating committee of the Company. The Board has approved his appointment and is of the view that Mr. Liew's appointment will be beneficial to the Board and to the Company. Role And Responsibilities: Non-executive.

Job Title: Independent director, chairman of the audit committee and member of the nominating committee of the Company. Director Experience Details: Mr. Liew is currently (i) the independent non-executive chairman, the chairman of the audit committee and a member of the nominating committee and remuneration committee of Grand Venture Technology Limited and (ii) an independent non-executive director, the chairman of the audit committee and a member of the remuneration committee of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, companies which are listed on the SGX-ST. Mr. Liew was also previously (i) the executive chairman and chief executive officer and a member of the nominating committee of Hoe Leong Corporation Limited; (ii) an independent non-executive director of Shanghai Turbo Enterprises Limited and (iii) an independent non-executive director, the chairman of the remuneration committee and a member of the audit committee and nominating committee of Innovalues Limited, companies which are listed on the SGX-ST.

Professional Qualifications: Bachelor of Commerce (Accountancy) - Nanyang University Fellow of the Association of Chartered Certified Accountants Fellow of the Institute of Singapore Chartered Accountants. The Board refers to the Company's announcements dated 15 September 2023, 18 September 2023 and 29 September 2023 (the "Announcements") in relation to the resignation of Mr. Gavin Mark McIntyre ("Mr McIntyre") as an independent director of the Company and his cessation as the Non- Executive Chairman of the Board, chairman of the AC and a member of the NC and the remuneration committee ("RC") of the Company, with effect from 30 November 2023. As set out in the Announcements, Mr. McIntyre has decided to resign as an independent director of the Company and the Non-Executive Chairman of the Board due to personal reasons arising from increased family commitment to attend to close family member's medical care.

The Board wishes to announce that since the Announcements, as a result of an improvement in the condition of Mr. McIntyre's family member and the alleviation of his increased family commitment, and the appointment of Mr. Liew as an independent director of the Company, the chairman of the AC and a member of the NC, the Board has further deliberated and discussed with Mr. McIntyre on his resignation as an independent director of the Company. Given the afore-mentioned change in circumstances, Mr. McIntyre has offered to withdraw his notice of resignation, and the NC (excluding Mr. McIntyre), being satisfied with the reasons provided by Mr. McIntyre, has consented to the withdrawal of his resignation. Accordingly, Mr. McIntyre WILL NOT be resigning as an independent director of the Company and the Non-Executive Chairman of the Board on 30 November 2023.

He will however, relinquish his role as the Chairman of the AC and be re- designated as a member of the AC, and will cease to be a member of the NC, with effect from 27 November 2023. Mr. McIntyre has affirmed his commitment to the Board and has confirmed that he will be able to devote sufficient time and resources to discharge his responsibilities as an independent director of the Company and the Non-Executive Chairman of the Board. Consequent to the above changes, the composition of the Board and the Board Committees of the Company will be as follows: Board of Directors: Mr. Gavin Mark McIntyre-Non-Executive Independent Chairman, Mr. Song Tang Yih-Executive Director and Chief Executive Officer, Mr. Ian David Brown-Independent Director, Ms. Ch'ng Li-Ling-Independent Director, Mr. Liew Yoke Pheng Joseph-Independent Director.

Audit Committee: Mr. Liew Yoke Pheng Joseph-Chairman, Mr. Gavin Mark McIntyre-Member, Mr. Ian David Brown-Member. Nominating Committee: Ms. Ch'ng Li-Ling-Chairman, Mr. Ian David Brown-Member, Mr. Liew Yoke Pheng Joseph-Member. Remuneration Committee: Mr. Ian David Brown-Chairman, Mr. Gavin Mark McIntyre-Member, Ms. Ch'ng Li-Ling-Member.